Iqvia Holdings Inc. – formerly QuintilesIMS – shared results from its recent study of medical apps and their impact in health care. Iqvia's Institute for Human Data Science study, "The growing value of digital health: evidence and impact on human health and the health care system," points to factors leading to app uptake and evidence of a care benefit.

Florida Atlantic University (FAU) and the University of Utah School of Medicine have teamed for an NIH-backed project to create a bioengineered robotic hand with a sense of touch. The "living" robotic hand is anticipated to have a functioning nervous system through a network of sensors and actuators. The project, "Virtual Neuroprosthesis: Restoring Autonomy to People Suffering from Neurotrauma," was awarded a four-year $1.3 million grant from NIH's National Institute of Biomedical Imaging and Bioengineering.

Ivantis Inc. reported primary and secondary endpoints have been met for a pivotal study of its Hydrus microstent micro-invasive glaucoma surgical (MIGS) device. Outcomes from the Horizon study have outstripped previous MIGS trials, according to the company, which anticipates FDA approval in 2018.

Stryker Corp. won an FDA humanitarian device exemption for its Neuroform Atlas stent. The device works in conjunction with neurovascular embolic coils for patients with wide neck, saccular and intracranial aneurysms. Wide neck aneurysms have a neck greater than 4 millimeters or have a dome to neck ratio of less than two.